Directly Observed Therapy for Community-Released HIV+ Prisoners

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

151 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-07-31

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to develop effective interventions for HIV-infected prisoners who are released to the community. The intervention that we will study will be directly observed therapy (DAART/DOT) and we will compare this to the current standard of care that involves self-administered therapy (SAT). All subjects will get transitional case management and all subjects with a prior history of opiate dependence will be offered opiate substitution therapy (buprenorphine or methadone).

Hypotheses:

* At the end of six months those receiving DAART will have a higher level of adherence to HAART as compared to the SAT group.
* The DAART Intervention will result in subjects having lower viral loads and higher CD4 counts as compared to the SAT group.
* At the end of six months, the DAART group will have a lower rate of recidivism to jail/prison as compared to the SAT group.
* Over the year, the DAART group will be more likely to make repeated primary HIV care visits than the SAT group.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Directly Observed Antiretroviral Therapy Among Active Drug Users

NCT00367172

HIV/AIDS Substance Abuse

COMPLETED NA

A Randomized Controlled Trial of HIV Testing and Linkage to Care at Community Corrections

NCT01366495

HIV

COMPLETED NA

Linking Persons With HIV, Discharged From Jail, With Community Care

NCT04560556

Human Immunodeficiency Virus

COMPLETED

Secondary HIV Prevention and Adherence Among HIV-infected Drug Users

NCT01741311

Risk Behavior Medication Adherence HIV

COMPLETED NA

An Intervention to Improve HIV Pre-exposure Prophylaxis Initiation, Adherence and Linkage to Care for Recently Incarcerated Men Who Inject Drugs.

NCT06316089

Hiv Substance Use Disorders

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Any individual that is HIV positive and incarcerated for at least a period of 90 days and on antiretroviral medications would be referred to the study by the medical staff of the incarceration facilities prior to release or within 30 days of release an individual would be able to self refer.

Subjects would be screened and consented and interviewed prior to their release from incarceration, on their day of release, and monthly for a period of one year. At the time of their day of release interview, subjects are randomized to either the intervention DAART group or the standard of care SAT group. All subjects would be assessed and offered opiate substitution therapy if there was a prior history of opiate dependency as a means of relapse prevention.

Subjects in DAART would be seen everyday for a period of six months by a team of research assistants who observe the subjects taking their medications, and their last six months would be done as standard of care. Standard of care SAT subjects would continue to take their medications on their own as prescribed. All subjects would be interviewed monthly and quarterly would have laboratory blood tests completed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV/AIDS Substance Abuse

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

DAART

Group that will be observed daily taking their medications for a period of six months. Followed by the remaining six months of the intervention in which the subject will take medications on their own.

Group Type EXPERIMENTAL

Directly administered antiretroviral therapy

Intervention Type BEHAVIORAL

Daily observation of subjects taking their HIV medications

2

SAT (standard of care) group will take their medications as directed by their physicians for the period of one year.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Directly administered antiretroviral therapy

Daily observation of subjects taking their HIV medications

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* HIV seropositive
* 18 years of age or older
* incarcerated for a minimum of 90days
* living in New Haven or Hartford
* currently on HAART or willing to begin HAART medications

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No